Richard B. Womer, MD

faculty photo
Professor of Pediatrics at the Children's Hospital of Philadelphia
Department: Pediatrics

Contact information
Children's Hospital of Philadelphia
3501 Civic Center Boulevard
10th Floor
Philadelphia, PA 19104
Office: (215) 590-2229
B.A. (Biology)
University of Rochester, 1974.
University of Rochester, 1978.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Description of Research Expertise

I conduct clinical and translational research on sarcomas in children, adolescents, and young adults, mostly through the Children's Oncology Group. My current projects include fusions of clinical and biological data from the COG AEWS0031 Ewing sarcoma study (which I chaired), and secondary clinical analyses of data from combined data sets including AEWS0031. As a member of the Executive Committee of the COG Bone Tumor Committee, I help determine the directions and priorities of its projects.

I also have a longstanding interest in medication safety, particularly chemotherapy safety, and co-chair a COG effort to standardize chemotherapy dosing and administration across diseases and protocols. Our committee has just begun to publish the results of this work.

Description of Clinical Expertise

My clinical practice in pediatric oncology focuses on solid tumors in children, particularly connective tissue tumors. These include soft tissue sarcomas (rhabdomyosarcoma and others), bone sarcomas (osteosarcoma and Ewing sarcoma), and fibromatoses.

Description of Other Expertise

I am almost always eager to discuss photography, choral singing, cooking, home brewing, canoeing, or hiking.

Selected Publications

Balis FM, Womer RB, Berg S, Winick N, Adamson PC, Fox E, Children’s Oncology Group Chemotherapy Standardization Task Force: : Dosing anticancer drugs in infants: Current approach and recommendations from the Children’s Oncology Group Chemotherapy Standardization Task Force. Pediatric Blood and Cancer May 2017.

Cash T, McIlvaine E, Krailo MD, Lessnick S, Lawlor ER, Laack N, Sorger J, Marina N, Grier HE, Granowetter L, Womer RB, Dubois SG: Comparison of clinical features and outcomes in patients with extraskeletal versus skeletal Ewing sarcoma: A report from the Children's Oncology Group. American Society of Clinical Oncology Annual Meeting 63(10): 1771-1779, Oct 2016.

Daw NC, Laack NN, McIlvaine EJ, Krailo M, Womer RB, Granowetter L, Grier HE, Marina NM, Bernstein ML, Gebhardt MC, Marcus KJ, Advani SM, Healey JH, Letson GD, Gorlick RG, Randall RL: Local control modality and outcome in Ewing sarcoma of the femur: A report from the Children’s Oncology Group. Annals of Surgical Oncology 23(11): 3541-3547, Oct 2016.

Kieuhoa TV, Edwards JV, Epling CL, Sinclair E, Hawkins DS, Grier HE, Janeway KA, Barnette P, McIlvaine E, Krailo MD, Barkauskas DA, Matthay KK, Womer RB, Gorlick RG, Lessnick SL, Mackall CL, DuBois SG: Impact of two different measures of micrometastatic disease on clinical outcomes in patients with newly diagnosed Ewing sarcoma: A report from the Children's Oncology Group Clinical Cancer Research 22: 3643-3650, July 2016.

Mascarenhas L, Felgenhauer JL, Bond MC, Villaluna D, Femino JD Laack NN, Ranganathan S, Meyer J, Womer RB, Gorlick R, Krailo MD, Marina N: Pilot study of adding vincristine, topotecan, and cyclophosphamide to interval-Compressed chemotherapy in newly diagnosed patients with localized Ewing Sarcoma: A report from the Children's Oncology Group. Pediatric Blood and Cancer 63: 493-498, Mar 2016.

Isakoff MS, Goldsby R, Villaluna D, Krailo MD, Gorlick R, Doski JJ, Womer RB, Janeway KA: Rapid protocol enrollment in osteosarcoma: A report from the Children’s Oncology Group. Pediatric Blood and Cancer 63, Feb 2016.

Karski EE, McIlvaine E, Segal MR, Krailo M, Grier HE, Granowetter L, Womer RB, Meyeres PA, Felgenhauer J, Marina N, DuBois DG: Identification of discrete prognostic groups in Ewing Sarcoma. Pediatric Blood and Cancer 63: 47-53, Jan 2016.

Lerman Daniel M, Monument Michael J, McIlvaine Elizabeth, Liu Xiao-qiong, Huang Dali, Monovich Laura, Beeler Natalie, Gorlick Richard G, Marina Neyssa M, Womer Richard B, Bridge Julia A, Krailo Mark D, Randall R Lor, Lessnick Stephen L: Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: a report from the Children's Oncology Group. Pediatric blood & cancer 62(5): 759-65, May 2015.

Volchenboum Samuel L, Andrade Jorge, Huang Lei, Barkauskas Donald A, Krailo Mark, Womer Richard B, Ranft Andreas, Potratz Jenny, Dirksen Uta, Triche Timothy J, Lawlor Elizabeth R: Gene Expression Profiling of Ewing Sarcoma Tumors Reveals the Prognostic Importance of Tumor-Stromal Interactions: A Report from the Children's Oncology Group. The journal of pathology. Clinical research 1(2): 83-94, Apr 2015.

DuBois Steven G, Krailo Mark D, Gebhardt Mark C, Donaldson Sarah S, Marcus Karen J, Dormans John, Shamberger Robert C, Sailer Scott, Nicholas Richard W, Healey John H, Tarbell Nancy J, Randall R Lor, Devidas Meenakshi, Meyer James S, Granowetter Linda, Womer Richard B, Bernstein Mark, Marina Neyssa, Grier Holcombe E: Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: a report from the Children's Oncology Group. Cancer 121(3): 467-75, Feb 2015.

back to top
Last updated: 03/12/2018
The Trustees of the University of Pennsylvania